Long-Term Effects of Cancer Treatment

A right hemicolectomy removes the right side of the colon, usually to treat a tumour in that area, and joins the remaining healthy bowel back together. Most people spend a few days in hospital and are encouraged to walk soon after surgery to help recovery.

Bowel habits often change for a few weeks afterward — looser stools or more frequent trips to the toilet are common while the bowel adapts, and this usually settles with time and dietary adjustment. Full recovery of energy and normal eating typically takes 4–6 weeks, longer if chemotherapy follows.

Chemotherapy affects fast-dividing cells throughout the body, which is why side effects like fatigue, hair thinning, nausea, and lowered immunity are common alongside its effect on the cancer itself. Energy levels and appetite often dip during a cycle and recover in the days before the next one.

Mood and personality changes are also frequently reported — irritability, low motivation, anxiety, or "chemo brain" (mild memory and concentration fog) can appear during treatment. These effects are usually temporary and tend to improve gradually after treatment ends, though timelines vary from person to person.

Bicalutamide blocks testosterone from reaching prostate cancer cells, slowing their growth. It's often combined with other hormone treatments (LHRH injections) for a stronger effect.

Common effects include hot flashes, breast tenderness or swelling, reduced sex drive, and fatigue, since the treatment lowers the body's exposure to male hormones. These effects usually ease if the medication is stopped or adjusted by your doctor.

Letrozole belongs to a class called aromatase inhibitors, used mainly in hormone-receptor-positive breast cancer in postmenopausal women. It works by blocking the body's production of estrogen, which many breast cancers rely on to grow.

Because estrogen levels drop, joint stiffness, hot flashes, and bone thinning (osteoporosis) are the most reported effects — bone density is often monitored during long-term use. Cholesterol levels can also shift, so periodic blood tests are typical.

Docetaxel is a taxane chemotherapy that stops cancer cells from dividing by interfering with their internal skeleton. It's used across several cancers, including breast, lung, and prostate cancer.

Hair loss, nail changes, fluid retention, and numbness or tingling in the hands and feet (neuropathy) are common with taxanes. Blood counts are checked regularly, as it can temporarily lower white blood cells and raise infection risk.

Zoladex (goserelin) is an injectable implant that suppresses the hormones driving certain breast and prostate cancers, effectively pausing the ovaries or testes' hormone production. It's usually given as a monthly or 3-monthly injection under the skin.

Menopause-like symptoms are typical — hot flashes, mood swings, reduced bone density over time, and changes in libido. These effects generally reverse once injections stop, though bone health is often monitored during longer courses.

Zytiga (abiraterone) is used in advanced prostate cancer and works by blocking testosterone production not just in the testes but also in the adrenal glands and the tumour itself. It's taken as a tablet, usually alongside a steroid and ongoing hormone therapy.

Because it also affects the adrenal glands, it can raise blood pressure, cause fluid retention, and affect liver function, so blood pressure and liver enzymes are checked regularly during treatment.

BEP is a combination chemotherapy regimen most often used for germ cell tumours, including testicular cancer, given in cycles over several weeks. Each drug attacks cancer cells in a different way, which increases effectiveness but also broadens the side-effect profile.

Nausea, fatigue, and hair loss are common with the combination; bleomycin specifically requires monitoring of lung function, as it can occasionally affect the lungs with cumulative doses. Kidney function is also checked regularly because of the cisplatin component.

Blood cancers like Hodgkin's lymphoma and leukemia are typically treated with multi-drug chemotherapy regimens (such as ABVD for Hodgkin's) given in cycles, since these cancers involve cells circulating through the blood and lymphatic system rather than a single solid tumour.

Because these treatments affect the bone marrow directly, low blood counts, fatigue, and increased infection risk are especially closely monitored, alongside the more general chemotherapy effects like nausea and hair loss.

Neupogen (filgrastim) is not a chemotherapy drug itself — it's a supportive injection that stimulates the bone marrow to produce more white blood cells, given after chemotherapy to help the body recover and lower infection risk.

The most common effect is bone or muscle ache, often in the lower back, hips, or breastbone, as the marrow ramps up production; this is usually manageable with mild pain relief and settles once the course finishes.

Carboplatin and paclitaxel (Taxol) are frequently paired together, especially in ovarian and lung cancers, because they attack cancer cells through different mechanisms and work well in combination.

Together they commonly cause hair loss, fatigue, numbness or tingling in the hands and feet, and a temporary drop in blood counts. An allergic-type reaction can occur with paclitaxel, so the first infusions are usually given slowly with monitoring.

Radiation aimed at the head, neck, or jaw can reduce saliva production and affect the blood supply to the teeth and gums, making cavities and gum problems more likely afterward — a dental check-up before and after radiation is generally recommended.

On the skin, radiation used to treat skin cancers or as part of treatment for tumours elsewhere in the body often causes redness, dryness, or peeling in the treated area, similar to a sunburn, which typically heals within a few weeks of finishing treatment.